Radiopharmaceuticals and Tracers

The past year saw the release of several new, innovative technologies to improve nuclear imaging in both positron emission tomography (PET) and single-photon emission computed tomography (SPECT). 

Neuraceq, florbetaben, F18, F-18, Piramal, alzheimer's

The U.S. Food and Drug Administration (FDA) has approved a third beta-amyloid plaque positron emission tomography (PET) imaging radiotracer to identify Alzheimer’s disease. The FDA’s approval of Piramal Imaging’s Neuraceq (florbetaben F-18 injecti...

PET vs. SPECT, nuclear imaging advances

Just when positron emission tomography (PET) appears to be eclipsing single photon emission computed tomography (SPECT) for cardiac imaging, new advances make SPECT more attractive. Both modalities also have suffered setbacks with radiopharmaceuti...

NorthStar, RadioGenix, isotopes, separation system, Tc-99m
NorthStar Medical Radioisotopes LLC will unveil the commercial model of its RadioGenix isotope separation system during three events on March 27 and March 28...
NOPR, CMS, PET, NaF-18, comment period, bone metastasis
The National Oncologic PET Registry (NOPR) Working Group submitted a formal request to the Centers for Medicare and Medicaid Services (CMS), to end the...
light therapy, radiation oncology, radiopharmaceuticals, PET
Using a mouse model of cancer, researchers at Washington University School of Medicine in St. Louis have devised a way to apply light-based therapy to deep...
radiotherapeutics, nuclear medicine, PET, SPECT, MEDraysintell
The first annual financial results of Xofigo (radium-223 dichloride) from Bayer are in line with the MEDraysintell analysis showing that the growth of nuclear...
Navidea Biopharmaceuticals' Inc. Lymphoseek (technetium Tc 99m tilmanocept) injection is U.S. Food and Drug Administration (FDA)-
Navidea Biopharmaceuticals’ Lymphoseek (technetium Tc-99m tilmanocept) injection is a radioactive diagnostic imaging agent, approved by the...
The U.S. Food and Drug Administration (FDA) designated the Society of Nuclear Medicine and Molecular Imaging's (SNMMI's) ...

Articles

light therapy, radiation oncology, radiopharmaceuticals, PET
Using a mouse model of cancer, researchers at Washington University School of Medicine in St. Louis have devised a way to apply light-based therapy to deep...
The U.S. Food and Drug Administration (FDA) has approved for human evaluation a nanoparticle-based imaging agent jointly developed at Washington...
Navidea Biopharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved the Supplemental New Drug Application (sNDA) for...
June 13, 2014 — The U.S. Food and Drug Administration (FDA) today approved a new use for Navidea Biopharmaceuticals’ Lymphoseek (technetium Tc-99m tilmanocept...

Video Center

It’s been no secret that the American healthcare system needed to change to survive economically...
6 weeks 4 days ago
In 1934, a Senate committee opened hearings its chairman said would show that America’s involvement...
7 weeks 4 days ago
The silence is deafening. And since radiology associations, physician groups and vendors have yet...
8 weeks 4 days ago
Centricity, webinar, ZFV, ZFP, viewer, remote viewing system, enterprise
Healthcare organizations are demanding more capabilities for image viewers accessed by clinicians. Zero footprint (ZFP) viewers provide imaging tools from...
The webinar "State of the Art in MRI Pediatric Brain Perfusion Imaging" educates participants about the state of the art clinical and emerging translational...
This webinar discusses why contemporary adult cardiac interventions require significant ionizing radiation with potential health risks to both the patient and...

Comparison Charts

Sorry there is no data available